U.S. Markets closed

Novacyt S.A. (NVYTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
4.1800+0.4800 (+12.97%)
At close: 1:03PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.7000
Open4.1800
BidN/A x N/A
AskN/A x N/A
Day's Range4.1800 - 4.1800
52 Week Range0.6595 - 6.5500
Volume510
Avg. Volume2,527
Market CapN/A
Beta (5Y Monthly)-2.24
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters

    Diagnostics group Novacyt to launch more COVID-19 testing products

    Clinical diagnostics company Novacyt - one of many healthcare companies whose shares have surged during the pandemic - announced on Monday more new products to test for the presence of the coronavirus. Novacyt said it was developing a respiratory testing panel to diagnose and distinguish between the 'A' and 'B' types of influenza, the respiratory syncytial virus (RSV) and COVID-19, with the launch of this product expected in September in time for the 2020/21 flu season in the northern hemisphere. "The immediate pipeline of new products is expected to drive incremental revenue for the company in the near-term, but Novacyt's strengthened financial position also means we are able to redefine our R&D pipeline for the next three years, which we expect to drive significant and continued growth opportunities in the longer-term," said Novacyt CEO Graham Mullis.

  • Investing.com

    StockBeat: Novacyt Starts to Deliver

    By Geoffrey Smith

  • How Much Are Novacyt S.A. (EPA:ALNOV) Insiders Spending On Buying Shares?
    Simply Wall St.

    How Much Are Novacyt S.A. (EPA:ALNOV) Insiders Spending On Buying Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...